Lotus Leaf (Nelumbo nucifera)

Nelumbo nucifera
Evidence Level
Preliminary
2 Clinical Trials
4 Documented Benefits
1/5 Evidence Score

Lotus leaf is the dried leaf of the lotus plant, Nelumbo nucifera, eaten as food and used in China as a traditional herb (He Ye). It is sold as a tea or extract for weight and blood lipid support. The leaves contain flavonoids, mainly quercetin 3-O-glucuronide in hot-water extracts, and alkaloids such as nuciferine. Most of the research is in cells and in mice and rats fed high-fat diets. Human evidence is thin: one 12-week trial of a lotus leaf extract drink, sponsored by a Meiji company and co-authored by Meiji researchers, reported less body fat than control, and one small trial tested a drink that also held potato extract and hydroxycitric acid. In lab tests, lotus leaf alkaloids block the drug-processing enzyme CYP2D6 and hERG, a potassium channel involved in heart rhythm. Lotus leaf is a different product from lotus seed and from blue lotus, which is a water lily.

Studied Dose 1 or 2 g/day of hot-water lotus leaf extract taken in two 200 mL drinks with or after meals for 12 weeks (trial registry); the published abstract does not state the dose.
Active Compound Flavonoids, mainly quercetin 3-O-glucuronide and quercetin in hot-water extracts, plus aporphine alkaloids, chiefly nuciferine and N-nornuciferine.

Benefits

Body fat in a 12-week trial of a lotus leaf extract drink

In a randomized double-blind trial in China in adults with a BMI of 24 to 28, 12 weeks of a hot-water lotus leaf extract lowered whole-body fat versus control in men and women, and visceral fat and waist size in men. It was a single trial sponsored by a Meiji company with Meiji co-authors; the abstract gives no dose or effect sizes, and a registry entry filed years later lists 95 rather than 60 participants.

Blood cholesterol in a trial of a potato and lotus leaf blend

In 19 female university students in Korea, 8 weeks of a drink combining potato and lotus leaf extracts with hydroxycitric acid lowered total cholesterol compared with placebo. Body fat, BMI, triglycerides, LDL and HDL did not differ significantly between groups. Because it was a blend, the result cannot be credited to lotus leaf itself.

Fat storage in rodents fed high-fat diets

In mice on a high-fat diet, a lotus leaf extract given for 5 weeks limited gains in body weight, fat pad weight and liver triglycerides. In obese rats, a water extract given for 6 weeks cut visceral fat by about 46 to 58% depending on dose. These are animal results only and do not show the same effect in people.

Nuciferine and fat metabolism in lab and animal studies

Nuciferine, a main alkaloid of lotus leaf, was added to a high-fat diet at 0.1% for 12 weeks in mice and reduced body weight and fat mass while raising energy expenditure. In rats on a high-fat diet it limited weight gain and shifted gut bacteria. These findings come from animals only.

Mechanism of action

1

Slows starch and fat digestion in lab tests

In test-tube work, lotus leaf extract blocked alpha-amylase and lipase, the enzymes that break down starch and fat, in a dose-dependent way. In muscle cells it raised lipid metabolism and expression of UCP3, a protein linked to energy use.

2

Quercetin glucuronide and fat breakdown in cells

Quercetin 3-O-glucuronide and quercetin are the key components of hot-water lotus leaf extract. In cell studies they promoted the breakdown of stored triglycerides through the cAMP pathway. This has not been measured in people.

3

AMPK signaling in liver and fat tissue

In mice and liver cells, nuciferine switched on AMPK, an energy-sensing enzyme, which lowered fat-making enzymes (SREBP1, FAS, ACC) and raised fat-breakdown enzymes (HSL, ATGL). Blocking AMPK removed these effects in cells.

4

Alkaloids act on dopamine receptors in lab tests

Alkaloids isolated from lotus leaves blocked dopamine D1 and D2 receptors in cell assays, and in rats nuciferine and N-nornuciferine were well absorbed by mouth and, when injected, rapidly reached the brain. What this means for appetite, mood or safety in people is unknown.

Clinical trials

1
Lotus Leaf Extract and Body Fat: 12-Week Randomized Trial (maker-affiliated)
PubMed

Randomized, double-blind trial of a hot-water extract of sun-dried lotus leaves (main component quercetin 3-glucuronide) for 12 weeks. Co-authors are from Meiji Co., Ltd., and the registry entry (NCT04651023) is sponsored by Shanghai Meiji Health Science and Technology. (Ye et al. 2022, Nat Prod Res)

Adults with overweight (BMI 24 to 28) in China; the abstract reports n = 60. The registry entry, filed in 2020 for a study run in 2009, lists 95 adults aged 40 to 60 with a BMI of 23 to 30 randomized to a placebo drink or 1 g/day or 2 g/day of extract.

Compared with non-intervention control groups, whole-body fat decreased significantly in men and women, and men also had significant reductions in visceral fat and waist circumference. The abstract gives no effect sizes, dose or blood lipid results, and calls the comparison groups non-intervention controls, while the registry describes a placebo drink.

2
Potato and Lotus Leaf Blend in Young Women: 8-Week Placebo-Controlled Study (blend)
PubMed

Randomized, placebo-controlled study of a drink made mainly from potato and lotus leaf extracts combined with hydroxycitric acid, prepared by a Korean company's health food laboratory; the lotus leaf amount is not stated. (Lee et al. 2015, J Exerc Nutrition Biochem)

19 female university students in Korea (9 blend, 10 placebo).

Total cholesterol fell from about 185 to 168 mg/dL with the blend while staying near 189 to 194 mg/dL on placebo, a significant group by time interaction. BMI, percent body fat, abdominal fat, triglycerides, LDL and HDL showed no significant difference between groups. With three active parts and 19 people, the trial cannot show an effect of lotus leaf itself.

Side effects and drug interactions

Common Potential side effects

Human safety data are sparse: the abstract of the lotus leaf extract trial does not report adverse events, and a review of lotus alkaloids concluded that their clinical safety remains unclear and that larger, longer human trials are needed.
Lotus leaf alkaloids blocked dopamine D1 and D2 receptors in cell tests, and in rats injected nuciferine reached the brain quickly. Whether usual tea or extract amounts affect the nervous system in people is unknown.
Safety in pregnancy, breastfeeding and children has not been established.
In lab tests, nuciferine and related lotus leaf alkaloids blocked hERG, a heart potassium channel whose blockade can disturb heart rhythm, and five commercial lotus leaf weight loss supplements varied widely in these alkaloids (up to 992 micrograms of nuciferine per daily dose). Effects on heart rhythm in people have not been studied; anyone with a heart rhythm condition or taking medicines that affect heart rhythm should ask a doctor before use.

Important Drug interactions

CYP2D6 substrates (for example dextromethorphan and metoprolol): lotus leaf extract and its alkaloids, including nuciferine, strongly inhibited CYP2D6 in human liver microsomes and reduced the breakdown of both drugs in rats. Ask a pharmacist before combining lotus leaf with any medicine processed by CYP2D6.
CYP1A2 substrates: nuciferine weakly inhibited CYP1A2 in lab tests (only at millimolar concentrations) and slowed clearance of the probe drug phenacetin in rats.
Metformin: in mice, nuciferine lowered metformin levels in the liver and briefly weakened its glucose-lowering effect; the researchers suggested spacing the two apart. People taking glucose-lowering medicines should check with their doctor first.

Frequently asked questions about Lotus Leaf (Nelumbo nucifera)

Is lotus leaf the same as lotus seed or blue lotus?

No. Lotus leaf is the leaf of Nelumbo nucifera and is sold for weight and lipid support. Lotus seed comes from the same plant but is a different part, and research on the leaf does not apply to the seed. Blue lotus is a water lily, Nymphaea caerulea, a separate plant usually sold as a relaxation tea.

Does lotus leaf tea help with weight?

The human evidence is very thin. One 12-week trial of a lotus leaf extract drink, sponsored by a Meiji company, reported less body fat than control, and a small trial of a potato and lotus leaf blend changed total cholesterol but not body fat. The rest is animal and lab work. The trial used a set extract dose, so results may not match home-brewed tea.

What is nuciferine?

Nuciferine is one of the main alkaloids in lotus leaf. In mice and rats on high-fat diets it reduced weight gain and fat mass, but those weight findings come from animals, not people. In lab tests it also blocks the liver enzymes CYP2D6 and CYP1A2, which matters for drug interactions.

Can I take lotus leaf with my medicines?

Check with a pharmacist first. Lotus leaf alkaloids strongly blocked the drug-processing enzyme CYP2D6 in lab and rat studies, which could raise levels of medicines such as dextromethorphan or metoprolol, and nuciferine interfered with metformin in mice. The interaction findings so far come from cells and animals, so safe spacing in people is not known.

What is Lotus Leaf?

Lotus leaf is the dried leaf of the lotus plant, Nelumbo nucifera, eaten as food and used in China as a traditional herb (He Ye). It is sold as a tea or extract for weight and blood lipid support. The leaves contain flavonoids, mainly quercetin 3-O-glucuronide in hot-water extracts, and alkaloids such as nuciferine.

What is Lotus Leaf used for?

Lotus Leaf is researched primarily for Weight Management. In a randomized double-blind trial in China in adults with a BMI of 24 to 28, 12 weeks of a hot-water lotus leaf extract lowered whole-body fat versus control in men and women, and visceral fat and waist size in men.

What is the recommended dosage of Lotus Leaf?

The clinically studied dose is 1 or 2 g/day of hot-water lotus leaf extract taken in two 200 mL drinks with or after meals for 12 weeks (trial registry); the published abstract does not state the dose. Always follow the product label and check with a healthcare provider for personal advice.

Is Lotus Leaf safe, and does it have side effects?

Side effects and cautions reported for Lotus Leaf include: Human safety data are sparse: the abstract of the lotus leaf extract trial does not report adverse events, and a review of lotus alkaloids concluded that their clinical safety remains unclear and that larger, longer human trials are needed. It may also interact with some medications. Lotus Leaf is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Lotus Leaf interact with any medications?

Possible interactions include: CYP2D6 substrates (for example dextromethorphan and metoprolol): lotus leaf extract and its alkaloids, including nuciferine, strongly inhibited CYP2D6 in human liver microsomes and reduced the breakdown of both drugs in rats. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Lotus Leaf?

NutraSmarts rates the evidence for Lotus Leaf as Preliminary (1 out of 5). It is backed by 2 clinical trials and 17 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(17 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Ye L, Wang X, Konno T, Gong X, Ding H, Yan H, Ji ZS, Liu E. Fat reducing effects of Nelumbo nucifera leaf extract in overweight patients. Nat Prod Res. 2022;36(18):4776-4781. doi: 10.1080/14786419.2021.2010196.PubMedUsed to support: Randomized double-blind trial (n = 60 in the abstract) of a hot-water extract of sun-dried lotus leaves, with quercetin 3-glucuronide as the main component, in adults with overweight (BMI 24 to 28) for 12 weeks. Compared with non-intervention control groups, whole-body fat fell in men and women, and visceral fat and waist circumference fell in men. Several authors are from Meiji Co., Ltd. The abstract gives no dose or effect sizes.
  2. Shanghai Meiji Health Science and Technology Co., Ltd. Shanghai Meiji Health Science and Technology Co., Ltd (ClinicalTrials.gov record NCT04651023) ClinicalTrials.gov. 2020;NCT04651023. First posted 2020-12-03; study dates 2009-01-10 to 2009-06-20..SourceUsed to support: Not PubMed-indexed: trial registry entry (read via the ClinicalTrials.gov API), sponsored by Shanghai Meiji Health Science and Technology. Registered in 2020 for a study run in 2009. Lists 95 adults aged 40 to 60 with BMI 23 to 30 randomized to two 200 mL bottles a day containing 0 g (placebo), 1 g or 2 g of hot-water lotus leaf extract for 12 weeks, double-blind; primary outcomes were weight, body fat, visceral fat, waist and hip. No results are posted.
  3. Lee K, Kim J, Lee N, Park S, Cho H, Chun Y. Effects of potato and lotus leaf extract intake on body composition and blood lipid concentration. J Exerc Nutrition Biochem. 2015;19(1):25-30. doi: 10.5717/jenb.2015.19.1.25.PubMedUsed to support: Randomized placebo-controlled study in 19 female university students in Korea: 8 weeks of a drink combining potato and lotus leaf extracts with hydroxycitric acid gave a significant group by time interaction for total cholesterol only; BMI, percent body fat, abdominal fat, triglycerides, LDL and HDL did not differ significantly from placebo. A blend, so effects cannot be assigned to lotus leaf.
  4. Liu E, Tsuboi H, Ikegami S, Kamiyama T, Asami Y, Ye L, Oda M, Ji ZS. Effects of Nelumbo nucifera Leaf Extract on Obesity. Plant Foods Hum Nutr. 2021;76(3):377-384. doi: 10.1007/s11130-020-00852-w.PubMedUsed to support: Lab and animal study by researchers including Meiji staff: quercetin 3-O-glucuronide and quercetin were the key components of a hot-water lotus leaf extract; in cells they promoted triglyceride breakdown via the cAMP pathway, and the extract limited neutral fat accumulation in ICR mice.
  5. Ono Y, Hattori E, Fukaya Y, Imai S, Ohizumi Y. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J Ethnopharmacol. 2006;106(2):238-44. doi: 10.1016/j.jep.2005.12.036.PubMedUsed to support: Lotus leaf extract inhibited alpha-amylase and lipase in vitro, increased lipid metabolism and UCP3 expression in muscle cells, and over 5 weeks prevented increases in body weight, a fat pad weight and liver triglycerides in mice fed a high-fat diet. Animal and cell work only.
  6. Yan K, Zhu H, Xu J, Pan H, Li N, Wang L, Yang H, Liu M, Gong F. Lotus Leaf Aqueous Extract Reduces Visceral Fat Mass and Ameliorates Insulin Resistance in HFD-Induced Obese Rats by Regulating PPARγ2 Expression. Front Pharmacol. 2017;8:409. doi: 10.3389/fphar.2017.00409.PubMedUsed to support: In rats made obese on a high-fat diet, a lotus leaf water extract at 0.5 or 3.0 g crude drug/kg/day for 6 weeks reduced visceral fat mass by 45.5% and 58.4% and lowered fasting insulin; it also altered PPARgamma2 expression in cells and fat tissue. Animal and cell work only.
  7. Xu H, Lyu X, Guo X, Yang H, Duan L, Zhu H, Pan H, Gong F, Wang L. Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice. Nutrients. 2022;14(9):1898. doi: 10.3390/nu14091898.PubMedUsed to support: In mice fed a high-fat diet with 0.10% nuciferine for 12 weeks, body weight and fat mass fell, energy expenditure rose and liver fat decreased; nuciferine activated AMPK, lowered fat-making enzymes (SREBP1, FAS, ACC) and raised fat-breakdown enzymes (HSL, ATGL). The cell effects were blocked by an AMPK inhibitor. Animal and cell work only.
  8. Wang Y, Yao W, Li B, Qian S, Wei B, Gong S, Wang J, Liu M, Wei M. Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats. Exp Mol Med. 2020;52(12):1959-1975. doi: 10.1038/s12276-020-00534-2.PubMedUsed to support: In rats fed a high-fat diet for 8 weeks, nuciferine prevented weight gain, reduced fat accumulation, changed gut bacterial composition (lower Firmicutes/Bacteroidetes ratio, more short-chain fatty acid producers) and improved gut barrier markers. Animal work only.
  9. Ye LH, He XX, You C, Tao X, Wang LS, Zhang MD, Zhou YF, Chang Q. Pharmacokinetics of Nuciferine and N-Nornuciferine, Two Major Alkaloids From Nelumbo nucifera Leaves, in Rat Plasma and the Brain. Front Pharmacol. 2018;9:902. doi: 10.3389/fphar.2018.00902.PubMedUsed to support: Rat pharmacokinetics of a lotus leaf alkaloid fraction: nuciferine and N-nornuciferine, the two major alkaloids of the leaves, were rapidly absorbed after oral dosing (oral bioavailability estimated at 58% and 80%) and rapidly crossed the blood-brain barrier after intravenous dosing.
  10. Zhou H, Hou T, Gao Z, Guo X, Wang C, Wang J, Liu Y, Liang X. Discovery of eight alkaloids with D1 and D2 antagonist activity in leaves of Nelumbo nucifera Gaertn. Using FLIPR assays. J Ethnopharmacol. 2021;278:114335. doi: 10.1016/j.jep.2021.114335.PubMedUsed to support: Cell-based receptor assays: eight alkaloids isolated from lotus leaves blocked dopamine D1 receptors and seven blocked D2 receptors, with O-nornuciferine the most potent; O-nornuciferine also blocked serotonin 5-HT2A receptors. Lab work only.
  11. Ye LH, He XX, Kong LT, Liao YH, Pan RL, Xiao BX, Liu XM, Chang Q. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves. J Ethnopharmacol. 2014;153(1):190-6. doi: 10.1016/j.jep.2014.02.014.PubMedUsed to support: In human liver microsomes, a lotus leaf alcohol extract strongly inhibited the drug-metabolizing enzyme CYP2D6 and weakly inhibited CYP2C9, CYP2C19, CYP2E1 and CYP3A4; the alkaloid fraction and the alkaloids nuciferine, N-nornuciferine and 2-hydroxy-1-methoxyaporphine were competitive CYP2D6 inhibitors. The authors advise considering drug interactions.
  12. Ye LH, Kong LT, Yan MZ, Cao FR, Wang LS, Liao YH, Pan RL, Chang Q. Lotus leaf alkaloid fraction can strongly inhibit CYP2D6 isoenzyme activity. J Ethnopharmacol. 2016;194:913-917. doi: 10.1016/j.jep.2016.10.055.PubMedUsed to support: In rats given a lotus leaf alkaloid fraction (50 mg/kg) for 7 days, conversion of dextromethorphan and metoprolol to their CYP2D6 metabolites fell significantly; strong CYP2D6 inhibition was confirmed in human liver microsomes. The authors advise caution when combining lotus leaf preparations with conventional medicines.
  13. Hu L, Xu W, Zhang X, Su J, Liu X, Li H, Zhang W. In-vitro and in-vivo evaluations of cytochrome P450 1A2 interactions with nuciferine. J Pharm Pharmacol. 2010;62(5):658-62. doi: 10.1211/jpp.62.05.0015.PubMedUsed to support: Nuciferine inhibited recombinant human CYP1A2 in vitro only weakly (IC50 2.12 mmol/L), and oral nuciferine (20 mg/kg) in rats slowed clearance and prolonged the half-life of the CYP1A2 probe drug phenacetin. Animal and lab work only.
  14. Li L, Lei H, Wang W, Du W, Yuan J, Tu M, Zhou H, Zeng S, Jiang H. Co-administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1. Biopharm Drug Dispos. 2018;39(9):411-419. doi: 10.1002/bdd.2158.PubMedUsed to support: Nuciferine reduced metformin uptake through the transporters OCT1 and MATE1 in cells and, in mice, lowered liver metformin levels and briefly weakened its glucose-lowering effect at 30 and 60 minutes, with no difference by 90 to 120 minutes. The authors suggest spacing the two apart.
  15. Wang Z, Li Y, Ma D, Zeng M, Wang Z, Qin F, Chen J, Christian M, He Z. Alkaloids from lotus (Nelumbo nucifera): recent advances in biosynthesis, pharmacokinetics, bioactivity, safety, and industrial applications. Crit Rev Food Sci Nutr. 2023;63(21):4867-4900. doi: 10.1080/10408398.2021.2009436.PubMedUsed to support: Review of lotus alkaloids: describes their presence in seeds, leaves and other parts, relatively low bioavailability, and animal findings; concludes that clinical efficacy and safety remain unclear and larger, longer human trials are needed.
  16. Dosoky NS, Shah SA, Dawson JT, Banjara SS, Poudel A, Bascoul C, Satyal P. Chemical Composition, Market Survey, and Safety Assessment of Blue Lotus (Nymphaea caerulea Savigny) Extracts. Molecules. 2023;28(20):7014. doi: 10.3390/molecules28207014.PubMedUsed to support: Describes blue lotus as a water lily, Nymphaea caerulea, consumed as a tea or tincture for relaxation; a different plant from Nelumbo nucifera. Cited only to distinguish the two products.
  17. Grienke U, Mair CE, Saxena P, Baburin I, Scheel O, Ganzera M, Schuster D, Hering S, Rollinger JM. Human Ether-à-go-go Related Gene (hERG) Channel Blocking Aporphine Alkaloids from Lotus Leaves and Their Quantitative Analysis in Dietary Weight Loss Supplements. J Agric Food Chem. 2015;63(23):5634-9. doi: 10.1021/acs.jafc.5b01901.PubMedUsed to support: Lab study: an alkaloid fraction of lotus leaves blocked about half of the hERG heart potassium channel current at 100 micrograms/mL, and nuciferine, O-nornuciferine and N-nornuciferine blocked hERG in human cells (IC50 2.89, 7.91 and 9.75 micromolar). hERG blockade can cause dangerous heart rhythm disturbances. Five commercial lotus leaf weight loss supplements differed widely in these alkaloids, with up to 992 micrograms of nuciferine in the daily recommended dose. No human data.